SC
CVET

Sarissa Consulting’s Covetrus, Inc. Common Stock CVET Stock Holding History

Sarissa Consulting’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$661K Buy
+31,651
New +$659K 0.68% 39

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sarissa Consulting's CVET Position: Q3 2022 in Review

Sarissa Consulting opened a new position in Covetrus, Inc. Common Stock (CVET) in Q3 2022: 31,651 shares worth $661K. The stake represents 0.68% of the portfolio and ranks #39 among its holdings.

250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

  • Sarissa Consulting held 31,651 shares of Covetrus, Inc. Common Stock worth $661K as of Q3 2022.
  • Covetrus, Inc. Common Stock was a new Sarissa Consulting position in Q3 2022.
  • Covetrus, Inc. Common Stock made up 0.68% of Sarissa Consulting's portfolio in Q3 2022, its #39 holding.
  • 250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Sarissa Consulting's 13F filing for Q3 2022, filed 14 Nov 2022.